Octapharma Research Site

Houston, Texas 77090

1 studies enrolling now · 5 studies all time

What they study most

Chronic Immune Thrombocytopenia, Chronic Lymphocytic Leukemia, Dermatomyositis, Hypogammaglobulinemia, Pediatric Chronic Inflammatory Demyelinating Polyneuropathy, Severe Haemophilia A

Studies at this site

• Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients — Recruiting now
• Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) — Completed
• Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) — Stopped early
• Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) — Completed
• Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A — Completed